Intravitreal bevacizumab administration for the treatment of chronic central serous chorioretinopathy

PURPOSE: To evaluate the effects of intravitreal bevacizumab (IVB) injection on chronic central serous chorioretinopathy (CSC). METHODS: In this prospective interventional case series, a total of 22 eyes of 22 patients, diagnosed with unresolved CSC for three months or longer, received 1.25 mg IVB i...

Descripción completa

Detalles Bibliográficos
Autores principales: Alishiri, Aliagha, Jadidi, Khosrow, Mosavi, Seyed Aliasghar, Torabi, Hamidreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896463/
https://www.ncbi.nlm.nih.gov/pubmed/31844791
http://dx.doi.org/10.1016/j.joco.2019.06.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896463/
https://www.ncbi.nlm.nih.gov/pubmed/31844791
http://dx.doi.org/10.1016/j.joco.2019.06.006

Ejemplares similares